Published in Br J Cancer on August 01, 1975
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer (1983) 1.00
Plasma lipids and prolactin in patients with breast cancer. Br J Cancer (1986) 0.96
Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer. Br J Cancer (1992) 0.79
Factors that promote the development of human breast cancer. Environ Health Perspect (1983) 0.75
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Adrenalectomy and hypophysectomy for advanced cancer of the breast. Lancet (1960) 3.63
Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology (1966) 2.72
Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians (1969) 2.15
Radioreceptor assay for prolactin and other lactogenic hormones. Science (1973) 1.56
Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet (1974) 1.45
Human prolactin: 24-hour pattern with increased release during sleep. Science (1972) 1.35
Recent studies on functions and control of prolactin secretion in rats. Recent Prog Horm Res (1972) 1.25
Plasma prolactin in breast cancer. Eur J Cancer (1973) 1.22
Mammotropic effect of prolactin enhanced by thyroidectomy. Nature (1974) 1.18
Circadian periodicity of serum prolactin concentration in man. Br Med J (1972) 1.18
Elevated serum prolactin levels after pituitary-stalk section in man. N Engl J Med (1971) 1.11
Prolactin and mammary gland carcinogenesis. The problem of human prolactin. Int J Cancer (1970) 1.05
Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation. Am J Obstet Gynecol (1973) 0.98
[Evolution of serum prolactin levels during menstrual cycle]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.91
Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice. J Natl Cancer Inst (1972) 0.87
Plasma prolactin and breast cancer. Cancer (1974) 0.85
In vitro binding of radioiodinated human placental lactogen to murine mammary gland. Eur J Cancer (1974) 0.80
Complete amino acid sequence of human seminal plasma beta-inhibin. Prediction of post Gln-Arg cleavage as a maturation site. FEBS Lett (1984) 1.33
Neonatal screening for congenital hypothyroidism in a developing country: problems and strategies. Indian J Pediatr (1987) 1.13
Evidence for a periodic release of LH in castrated male and female rats. Endocrinology (1972) 1.01
Characterization of a polypeptide from human seminal plasma with inhibin (inhibition of FSH secretion)-like activity. FEBS Lett (1984) 1.00
Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates. Br J Cancer (1986) 0.98
Lung tumour incidence in mice treated with hydrazine sulphate. Int J Cancer (1976) 0.97
Carcinogenicity of betel quid ingredients: feeding mice with aqueous extract and the polyphenol fraction of betel nut. Br J Cancer (1979) 0.97
Liver function tests in women using oral contraceptives. Indian J Med Res (1967) 0.96
Ectopic production of human placental lactogen by human breast tumors. Cancer (1977) 0.95
Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates. Br J Cancer (1990) 0.94
Ectopic human placental lactogen and beta-human chorionic gonadotropin in gastric fluid of patients with malignant and non-malignant conditions of the stomach. Oncology (1981) 0.92
Isolation & characterization of inhibin from human seminal plasma. Indian J Exp Biol (1981) 0.92
Ectopic production of human chorionic gonadotrophin by human breast tumours. Br J Cancer (1974) 0.92
Therapy of childhood hypothyroidism: a reappraisal. Indian Pediatr (1982) 0.91
Evidence for the prostatic origin of immunoreactive inhibin-like material in human seminal plasma. Int J Androl (1984) 0.91
Evidence for the presence of specific receptors for inhibin in human prostate. Indian J Exp Biol (1982) 0.88
Experimental studies on betel nut and tobacco carcinogenicity. Int J Cancer (1976) 0.88
Studies on the functional activity of organotypically cultured mouse ovary. J Embryol Exp Morphol (1966) 0.86
Studies on inhibin-like peptide in gastric juice and serum of patients with duodenal ulcers. J Endocrinol (1984) 0.86
Studies on sequential metabolic alterations in spontaneous mammary carcinogenesis. Br J Cancer (1967) 0.85
Xanthine oxidase acitivity in progressive spontaneous mammary carcinogenesis. Br J Cancer (1968) 0.85
Development of a radioimmunoassay for human seminal plasma inhibin. J Reprod Fertil Suppl (1979) 0.85
Effect of vasectomy on the prostatic function as indicated by seminal maltase activity. Contraception (1975) 0.85
A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett (1993) 0.84
Effect of an indigenous drug (Speman) on accessory reproductive functions of mice. Indian J Exp Biol (1976) 0.83
Prostate--an extrapituitary source of follicle-stimulating hormone (FSH): occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents. Prostate (1991) 0.83
Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study. Cancer (1990) 0.83
Levels of inhibin in human semen and accessory reproductive organs. Andrologia (1980) 0.83
A peptide in gastric secretion with inhibin-like properties. Clin Endocrinol (Oxf) (1982) 0.83
beta 2-Inhibin contains the active core of human seminal plasma beta-inhibin: synthesis and bioactivity. FEBS Lett (1985) 0.83
Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res (1993) 0.83
Inhibin in the human prostate. Arch Androl (1981) 0.82
Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction. Fertil Steril (1978) 0.82
Activity of bromoergocryptine, Mucuna pruriens and L-dopa in the control of hyperprolactinaemia. Neurol India (1978) 0.82
Influence of hormones and chemical carcinogen on murine leukaemia. Br J Cancer (1973) 0.82
Inhibin-like material--an immunohistologic marker for prostatic origin of metastases. Cancer Lett (1987) 0.82
Role of the prostate in the regulation of pituitary secretion of follicle stimulating hormone. Med Hypotheses (1984) 0.82
An attempt at biochemical characterisation of histologically well defined tumours. Br J Cancer (1966) 0.82
Serum prolactin levels in fertile and infertile men. Andrologie (1973) 0.82
Isolation & characterization of inhibin from human seminal plasma. Indian J Exp Biol (1978) 0.81
Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach. Br J Cancer (1985) 0.81
An electron microscopic study of spontaneous and experimentally induced leukemia in ICRC mice. Cancer Res (1974) 0.81
Sialic acid, sialyltransferase and neuraminidase levels in maternal plasma, urine and lymphocytes during pregnancy and post-partum period--a longitudinal study in women. Eur J Obstet Gynecol Reprod Biol (1983) 0.81
Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast. Cancer Lett (1993) 0.81
Long-term effects of vasectomy on prostatic function in men. J Reprod Fertil (1980) 0.80
Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett (1988) 0.80
Biosynthesis and localization of inhibin in human prostate. Prostate (1987) 0.80
Intracytoplasmic type A particles from mammary tumours and leukaemias of strain ICRC mice. Br J Cancer (1979) 0.80
In vitro binding of radioiodinated human placental lactogen to murine mammary gland. Eur J Cancer (1974) 0.80
Circulating levels of inhibin in cancer. Neoplasma (1984) 0.80
Anticancer screening of SAN-AB: an extract of marking nut, Semecarpus anacardium. Indian J Exp Biol (1971) 0.80
Effect of inhibin on testosterone metabolism by rat ventral prostate in vitro. Arch Androl (1987) 0.80
Immunocytochemical localization of follicle stimulating hormone in normal human stomach. Anat Rec (1990) 0.79
Alpha-amylase activity of human placenta. Indian J Biochem Biophys (1975) 0.79
Studies on biological macromolecules. 3. Effect of hydroxyurea exposure on the synthesis of macromolecules in a mammalian cell system in vitro. Exp Cell Res (1966) 0.79
Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol Int (1993) 0.79
Stimulation of ornithine decarboxylase in the rat prostate by seminal plasma inhibin. Int J Androl (1986) 0.79
Measurement of inhibin. Arch Androl (1980) 0.79
Serum inhibin levels after administration of hCG. Arch Androl (1984) 0.79
Paraendocrine behaviour of tumours of the gastrointestinal tract with reference to human placental lactogen. Br J Cancer (1980) 0.79
Inhibin in human placenta. Indian J Exp Biol (1981) 0.79
Betel quid chewing and oral cancer: experimental studies on hamsters. Int J Cancer (1979) 0.79
Isoniazid tumorigenicity in mice under different experimental conditions. Int J Cancer (1978) 0.79
Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection. Prostate (1987) 0.79
Biological studies with low and high molecular weight inhibin preparations. Int J Androl (1981) 0.79
Activation of murine leukaemia virus under different physiological conditions. Br J Cancer (1975) 0.78
Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line. Prostate (1994) 0.78
Can vasectomy reduce the incidence of prostatic tumor? Med Hypotheses (1982) 0.78
Effect of LH, prolactin and spermine on ATPase activity of human spermatozoa. Andrologia (1979) 0.78
Pituitaries of spayed mice of different strains: cytology and gonadotrophin content. J Endocrinol (1970) 0.78
The inhibitory effect of the cowhage plant-Mucuna pruriens-and L-dopa on chlorpromazine-induced hyperprolactinaemia in man. Neurol India (1978) 0.78
Biological studies on leukemia in the ICRC mouse. I. Effect of gonadectomy. Indian J Cancer (1971) 0.78
Spontaneous lesions in the new inbred 'ICRC' mouse and its F1 cross with C3H. Indian J Cancer (1972) 0.78
Antifertility effects in rats actively immunized with 80 kDa human semen glycoprotein. Indian J Exp Biol (1992) 0.78
Passive immunization against prostatic 'inhibin' peptide as a male contraceptive. Int J Androl (1992) 0.78
Presence of specific receptor binding sites for inhibin in rat spermatids. Andrologia (1983) 0.78